SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 2,160.51 |
Enterprise Value ($M) | 2,168.05 |
Book Value ($M) | 164.77 |
Book Value / Share | 1.07 |
Price / Book | 13.11 |
NCAV ($M) | 148.86 |
NCAV / Share | 0.96 |
Price / NCAV | 14.51 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | 0.05 |
Return on Assets (ROA) | 0.06 |
Return on Equity (ROE) | 0.22 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 5.18 |
Current Ratio | 5.92 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 317.94 |
Assets | 329.59 |
Liabilities | 169.09 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 233.66 |
Operating Income | 20.63 |
Net Income | 12.67 |
Earnings Per Share Basic And Diluted | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -31.41 |
Cash from Investing | -50.65 |
Cash from Financing | 72.70 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Darwin Global Management, Ltd. | 2.70 | -61.28 | |
13G/A | Vanguard Group Inc | 9.03 | -11.82 | |
13G/A | BlackRock Inc. | 7.10 | 17.91 | |
13G/A | State Street Corp | 5.45 | -20.75 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
412,211 | 2,333,492 | 17.66 | |
381,244 | 1,004,530 | 37.95 | |
494,018 | 1,032,645 | 47.84 | |
346,696 | 697,196 | 49.73 | |
(click for more detail) |
Similar Companies | |
---|---|
TELO – Telomir Pharmaceuticals, Inc. | TENX – Tenax Therapeutics, Inc. |
TFFP – TFF Pharmaceuticals, Inc. | THAR – Tharimmune, Inc. |
THTX – Theratechnologies Inc. |